- One type that is caused by gamma-interferon-secreting T cells
- Another type caused by IL-17-secreting T cells
Nature Medicine produced an incredibly boring video where the Stanford University doctor in charge of the study describes the research results in incredibly boring detail:
But what about the rest of us who are getting different kinds of treatments? Not to sound completely self involved but, does this new information mean anything for MSers who are taking something other than beta-interferon? Does anyone know of similar studies that compare cellular differences between patients taking other therapies? Or, are neurologists just rolling the dice when they prescribe drugs for us, hopefully not taking into consideration the really posh pharmaceutical company lunches and the hefty speaking fees?
What do you think?